Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa

This study tests an inhaled drug called ensifentrine in people with non-cystic fibrosis bronchiectasis, a lung condition that causes frequent infections and breathing problems. About 284 adults will receive either the drug or a placebo twice daily for at least 24 weeks. The main …

This study tests whether a nebulized drug called ensifentrine can reduce inflammation in the lungs of people with COPD. About 56 adults aged 40-80 who smoke or have smoked will receive both the drug and a placebo at different times to compare results. The main goal is to see chan…

This study tests whether a combination of two drugs (ensifentrine and glycopyrrolate) given through a nebulizer can improve lung function better than either drug alone in people with COPD. About 480 adults will take part. The goal is to see if the combo helps patients breathe eas…